A step ahead in the management of HFmrEF and HFpEF

Media formats available:

Strong evidence for colchicine in patients with chronic coronary disease
Strong evidence for colchicine in patients with chronic coronary disease
ESC 2020
Strong evidence for colchicine in patients with chronic coronary disease
- Aernoud Fiolet, MD
- Aernoud Fiolet, MD, PhD
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
ESC 2020
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
- Prof. Freek Verheugt, MD
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
ESC 2020
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
- Prof. Renato D. Lopes, MD, PhD
Updates in the 2020 AF guidelines
Updates in the 2020 AF guidelines
ESC 2020
Updates in the 2020 AF guidelines
- Prof. Isabelle van Gelder, MD

PACE-CME